Actively Recruiting
Study of Improved Detection of Serum HBsAg and Reversion Rates in Adults With Chronic Hepatitis B After Functional Cure
Led by Huashan Hospital · Updated on 2024-08-13
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand the rate at which hepatitis B surface antigen HBsAg returns in chronic hepatitis B patients who have tested negative for HBsAg after treatment. The study compares a new, more sensitive HBsAg NEXT assay with the current ARCHITECT HBsAg assay to measure HBsAg reversion at 48 weeks after stopping treatment. It focuses on patients who have achieved functional cure under interferon therapy and completed consolidation therapy.
CONDITIONS
Brief Title
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
Research Team
F
Fahong Li
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here